| Mepha Pharma AG - Atovaquon-Proguanil-Mepha Junior 62.5 / 25, Filmtabletten | | 67872 | | 02 | | Atovaquon-Proguanil-Mepha Junior 62.5 / 25 | | Filmtabletten | | P01BB51 | | Proguanil and Atovaquone | | 29.04.2021 | | |
| | Composition | | atovaquonum 62.5 mg, proguanili hydrochloridum 25 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carboxymethylamylum natricum A corresp. natrium 0.37 mg, silica colloidalis anhydrica, povidonum K 30, poloxamerum 188, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 8000, macrogolum 400, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Atovaquone | 62.5 mg | | Proguanil Hydrochloride | 25 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | color. | | | | color. | | | | | | Hypromellosum | | Überzug | | Macrogol | 400 | | | | | | | Poloxamer | 188 | | | | 30 | | | | | | | Silica Colloidalis Anhydrica | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 12 | PR | PR | A | | No |
|
|
